Product introduction:
Zonisamide is a benzoisozole derivative, which can inhibit the focus of epilepsy and block the diffusion rate of epileptic discharge. It is used to treat epilepsy that is ineffective to other drugs, especially partial seizures. It is effective for primary generalized seizures, mixed epilepsy, myoclonic seizures and epilepsy syndromes such as Lun Jia syndrome and West syndrome. However, it is usually used as adjuvant treatment of other first-line drugs.
CAS:68291-97-4
Molecular formula: C8H8N2O3S
Molecular weight: 212.23
Structural type:
Chemical property: White to yellowish crystalline or crystalline powder, odorless and bitter. It is very soluble in acetone, methanol, ethanol, ethyl acetate or acetic acid, and slightly soluble in water, n-hexane, ether or chloroform.
Product purpose: It is used for major seizures, minor seizures, localized seizures, status epilepticus and psychomotor seizures.